Plasminogen activator inhibitor-1 (PAI-1) is the main regulator of the fibrinolytic system.
血浆纤溶酶原激活物抑制剂(PAI) - 1是纤溶系统的主要调控因子。
A system and method for rupturing an encapsulated adhesive in a, sheet media (12) USES an activator unit (24).
一种使封装在片形介质(12)中的粘合剂破裂的系统和方法使用了激活装置(24)。
Conclusion The diabetic nephropathy patients have imbalance of plasma plasminogen activator and its inhibitor system.
结论:糖尿病肾病患者存在血浆纤溶酶原激活物及其抑制物系统失衡。
应用推荐